当前位置:
X-MOL 学术
›
Clin. Gastroenterol. Hepatol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Lipoprotein (a) in the Full Spectrum of Metabolic Dysfunction-associated Steatotic Liver Disease: Evidence From Histologically and Genetically Characterized Cohorts
Clinical Gastroenterology and Hepatology ( IF 11.6 ) Pub Date : 2024-12-11 , DOI: 10.1016/j.cgh.2024.10.018 Hong Fan, Matina Kouvari, Geltrude Mingrone, Jacob George, Georgios Papatheodoridis, Laura Valenzuela-Vallejo, Zhenqiu Liu, Xingdong Chen, Tiejun Zhang, Christos S. Mantzoros
Clinical Gastroenterology and Hepatology ( IF 11.6 ) Pub Date : 2024-12-11 , DOI: 10.1016/j.cgh.2024.10.018 Hong Fan, Matina Kouvari, Geltrude Mingrone, Jacob George, Georgios Papatheodoridis, Laura Valenzuela-Vallejo, Zhenqiu Liu, Xingdong Chen, Tiejun Zhang, Christos S. Mantzoros
Lipoprotein(a) (Lp(a)) is an emerging biomarker for cardiometabolic factors. We studied the role of Lp(a) in the full spectrum of metabolic dysfunction-associated steatotic liver disease (MASLD).
中文翻译:
脂蛋白 (a) 在代谢功能障碍相关脂肪性肝病的全部谱中:来自组织学和遗传学特征队列的证据
脂蛋白 (a) (Lp(a)) 是心脏代谢因子的新兴生物标志物。我们研究了 Lp(a) 在代谢功能障碍相关脂肪性肝病 (MASLD) 的全部谱中的作用。
更新日期:2024-12-11
中文翻译:
脂蛋白 (a) 在代谢功能障碍相关脂肪性肝病的全部谱中:来自组织学和遗传学特征队列的证据
脂蛋白 (a) (Lp(a)) 是心脏代谢因子的新兴生物标志物。我们研究了 Lp(a) 在代谢功能障碍相关脂肪性肝病 (MASLD) 的全部谱中的作用。